A Study of Ustekinumab in Pediatric Participants (U-POPS) With Juvenile Psoriatic Arthritis or Psoriasis
Clinical trial NCT05252533 · COMPLETED
Trial details
- NCT number
- NCT05252533
- Sponsor
- Janssen Research & Development, LLC
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2022-05-24
- Primary completion
- 2024-01-26
- Enrollment
- 31
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.